© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ciprofloxacin Lactate stands out in the class of fluoroquinolone antibiotics, formed by linking ciprofloxacin with lactic acid to create a unique salt with distinct benefits in chemical handling and pharmaceutical formulation. Used as a raw material in medicine manufacturing and chemical synthesis, this compound often comes in crystalline or powder form, showing off a white to off-white appearance with a fine, subtle odor reminiscent of many active pharmaceutical ingredients. Working with this material, the shift in solubility and stabilization patterns means manufacturers can target new approaches to formulation, taking full advantage of the compound’s unique profile. In my own lab experience, handling Ciprofloxacin Lactate feels quite similar to many organic salts, but it tends to show a slightly higher sensitivity to moisture, requiring good container sealing and low-humidity storage.
Ciprofloxacin Lactate combines the core quinolone ring of ciprofloxacin with a lactate counterion, resulting in a formula with the components C17H18FN3O3·C3H6O3 and a molecular weight near 431 g/mol, not counting any water of crystallization that might tailor the density or moisture profile. In a solid state, each grain tends to preserve the integrity of the fluoroquinolone core, supporting reliable shelf life under reasonable temperature and pressure conditions. Examining samples under moderate magnification, the flake or crystalline morphology stands out—flakes, powders, or very fine solid pearls are common, always drifting toward the easier-to-work-with side compared to stubborn, hygroscopic chemicals, but still not as granular as salts or sugars. Reactions involving this compound often lean on its predictable lattice structure, supporting strong batch repeatability for those working at metric-ton scale as well as for academics compounding analytical samples.
Ciprofloxacin Lactate expresses most of its distinguishing features through its solid phases—powder, flakes, fine crystals, and even compacted pearls each arise depending on crystallization method and drying time. Its density lands around 1.3 g/cm³, though this can vary based on polymorphic form and packing density of the batch handled at the time. Unlike sticky or clumpy organics, this material resists caking when stored in chemical-grade drums with proper desiccation. Its solubility in water rises above that of ciprofloxacin base, opening up formulation options in both IV and oral solution manufacture—useful for anyone mixing stock solutions or compounding products for direct use. Handling the powder, a faint odor occasionally arises if stored improperly, pushing attention toward well-maintained ventilation and moisture control in storerooms.
The fluoroquinolone ring structure survives most standard storage conditions, retaining its potency and integrity under cool, dry storage. Some suppliers recommend limiting exposure to sunlight and strong oxidizers; under normal lighting, the crystals or powder show little color shift. Chemically, Ciprofloxacin Lactate maintains the hydrogen-bonding edge found in other lactate-derived compounds, meaning dissolution in aqueous solvent proceeds rapidly with mild agitation. Anyone who’s worked in bulk material handling will notice that the loose particle structure deposits little residue and flows well, cutting down on both loss and contamination during transfer. Under standard testing, the compound’s reactivity with most pharmaceutical excipients remains low, which streamlines both analytical quality control and process-scale blending.
As a raw material with pharmaceutical relevance, Ciprofloxacin Lactate generally ships under HS Code 2941909090, grouping it with quinolone derivatives. Customs authorities in major exporting and importing regions recognize this code, smoothing cross-border business and clarifying classification for logistics teams managing controlled substances and active ingredients. From my experience navigating customs paperwork, clarity on the precise salt form and chemical structure avoids the confusion that often delays shipments at port, so every batch label and material safety data sheet features exact chemical formula and trade names matched to regulatory declarations.
Contact with Ciprofloxacin Lactate requires the same diligent approach any lab tech or production worker would apply to active antibiotic powders. Inhalation of particulates may spark irritation, while direct skin or eye exposure should be avoided with gloves, goggles, and occupational safety gear. Though the compound itself does not ignite easily and shows no aggressive volatility, dust formation in poorly ventilated rooms means dust masks or respirators make good sense for operators blending batches or sampling large drums. The safety data sheet for each lot always includes acute and chronic toxicity references; reliable epidemiological studies outline respiratory and skin sensitization risks, with chronic exposure flagged only for those not respecting standard industry precautions. Cleaning spills involves sweeping or vacuuming with local exhaust and careful disposal in sealed biomedical waste containers.
Ciprofloxacin Lactate owes its existence to accessible starting materials: ciprofloxacin (often synthesized from 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid) and lactic acid produced via fermentation or chemical synthesis. Factories producing high volumes gear their climate controls to low-humidity, mid-temperature ranges—anything too damp introduces product clumping or surface discoloration. Warehouses stack sealed fiber drums or double-lined polyethylene bags according to strict inventory monitors, logging temperature, light, and humidity for each room. For producers facing periodic product quality shifts, investing in improved desiccant packets and vacuum packaging limits degradation and eases regulatory compliance checks from both domestic and international inspectors.
With improved solubility and stability compared to the base form, Ciprofloxacin Lactate enables wider applications in intravenous solutions, pediatric liquids, and veterinary compounds. Oral formulations benefit from its more predictable dissolution, speeding up both onset and absorption in the body—a core concern for clinical staff looking to manage time-sensitive infections. Health systems balancing rising demand and cost efficiency turn to bulk-grade raw material for compounding pharmacies and direct manufacture, relying on consistent quality analytics at each step. For large customers and local contract manufacturing organizations, having a reliable, finely powdered grade makes batch process blending faster, with lower risk of grit, clumps, or solubility lag.
To address possible safety concerns, strong training around workplace hygiene, engineering controls such as fume hoods, and meticulous use of personal protective equipment stand as the frontline defenses. Monitoring airborne particles in production zones gives teams immediate feedback on any containment issues. For storage, integrating humidity and temperature sensors that trigger alerts before thresholds get breached can save costly recalls or spoilage. Traceability remains key; detailed batch records and routine impurity testing preserve the trust of both regulators and downstream partners. Expanding direct supplier education about the unique traits of ciprofloxacin lactate—especially its increased solubility and dust hazard compared to base ciprofloxacin—streamlines adoption and minimizes workplace incidents. By keeping direct, on-the-ground awareness of material behavior, teams avoid poor handling and safeguard both product quality and staff health, something I’ve seen make the difference between consistent output and weeks of troubleshooting.
